Kusajili – Clinical trials directory

Result of your search per sponsor: Institut Jules Bordet - Université Libre de Bruxelles

Woman and Man Max 99 years
Institut Jules Bordet - Université Libre de Bruxelles Update Il y a 4 ans

A study to assess the safety and immunogenicity of an anti leukemia Antigen-Specific Cancer Immunotherapeutic (ASCI) combined with infusions of T lymphocytes in in vivo regulatory T cells depleted patients as post-consolidation therapy for adult patients with WT1-positive Acute Myeloid Leukemia (AML) Co-primary Objectives : To evaluate the safety of combined treatment strategy of WT1-A10 + AS01B, infusions of ex vivo regulatory T cells depleted T lymphocytes and in vivo regulatory T cells deplet...

Country None
organs None
Specialty None

unknown

More information